118 related articles for article (PubMed ID: 20122610)
1. Predictors of mortality within three months in the patients with malignant pleural effusion.
Ozyurtkan MO; Balci AE; Cakmak M
Eur J Intern Med; 2010 Feb; 21(1):30-4. PubMed ID: 20122610
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of pleural fluid data in patients with malignant effusion.
Bielsa S; Salud A; Martínez M; Esquerda A; Martín A; Rodríguez-Panadero F; Porcel JM
Eur J Intern Med; 2008 Jul; 19(5):334-9. PubMed ID: 18549935
[TBL] [Abstract][Full Text] [Related]
3. Predictors of talc pleurodesis outcome in patients with malignant pleural effusions.
Yildirim H; Metintas M; Ak G; Metintas S; Erginel S
Lung Cancer; 2008 Oct; 62(1):139-44. PubMed ID: 18403045
[TBL] [Abstract][Full Text] [Related]
4. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
[TBL] [Abstract][Full Text] [Related]
5. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma.
Crnjac A; Sok M; Kamenik M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):432-6. PubMed ID: 15296910
[TBL] [Abstract][Full Text] [Related]
6. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
7. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success.
Aydogmus U; Ozdemir S; Cansever L; Sonmezoglu Y; Kocaturk CI; Bedirhan MA
Ann Surg Oncol; 2009 Mar; 16(3):745-50. PubMed ID: 19116753
[TBL] [Abstract][Full Text] [Related]
8. Video-assisted thoracoscopic pleurodesis for malignant pleural effusions.
Füredi A; Kecskés L; Gehér P; Kiss B
Acta Chir Hung; 1999; 38(2):155-7. PubMed ID: 10596319
[TBL] [Abstract][Full Text] [Related]
9. Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis.
Sioris T; Sihvo E; Salo J; Räsänen J; Knuuttila A
Eur J Surg Oncol; 2009 May; 35(5):546-51. PubMed ID: 18644696
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of video-assisted thoracoscopic surgery vs thoracic tube drainage in synthetic therapy for malignant pleural effusion secondary to non-small cell lung cancer].
Gu LJ; Wang WJ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1023-6. PubMed ID: 16864104
[TBL] [Abstract][Full Text] [Related]
11. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
[TBL] [Abstract][Full Text] [Related]
12. Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients.
Ak G; Metintaş M; Yildirim H; Metintaş S; Dündar E; Erginel S; Alataş F
Tuberk Toraks; 2009; 57(1):22-31. PubMed ID: 19533434
[TBL] [Abstract][Full Text] [Related]
13. Rapid pleurodesis in symptomatic malignant pleural effusion.
Yildirim E; Dural K; Yazkan R; Zengin N; Yildirim D; Gunal N; Sakinci U
Eur J Cardiothorac Surg; 2005 Jan; 27(1):19-22. PubMed ID: 15621465
[TBL] [Abstract][Full Text] [Related]
14. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
15. Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: the importance of an early intervention.
Marrazzo A; Noto A; Casà L; Taormina P; Lo Gerfo D; David M; Mercadante S
J Pain Symptom Manage; 2005 Jul; 30(1):75-9. PubMed ID: 16043010
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of pleural fluid pH in malignant epithelial mesothelioma after talc poudrage.
Aelony Y; Yao JF; King RR
Respiration; 2006; 73(3):334-9. PubMed ID: 16679752
[TBL] [Abstract][Full Text] [Related]
17. [Tetracycline pleurodesis for treatment of malignant pleural effusions. Retrospective study of 91 cases].
Martínez Moragón E; Aparicio Urtasun J; Sanchis Aldás J; Fullana Monllor J; Sanchis Moret F; Montalar Salcedo J; Marco Martínez V
Med Clin (Barc); 1993 Jul; 101(6):201-4. PubMed ID: 8332018
[TBL] [Abstract][Full Text] [Related]
18. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
Neragi-Miandoab S; Richards WG; Sugarbaker DJ
Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
[TBL] [Abstract][Full Text] [Related]
19. Video-assisted management of malignant pleural effusion in breast carcinoma.
Gasparri R; Leo F; Veronesi G; De Pas T; Colleoni M; Maisonneuve P; Pelosi G; Galimberti V; Spaggiari L
Cancer; 2006 Jan; 106(2):271-6. PubMed ID: 16342163
[TBL] [Abstract][Full Text] [Related]
20. [Pleural mesothelioma: experience with 62 cases in 9 years].
Villena Garrido V; López Encuentra A; Echave-Sustaeta J; Alvarez Martínez C; Rey Terrón L; Sotelo MT; Ballestín C
Arch Bronconeumol; 2004 May; 40(5):203-8. PubMed ID: 15117619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]